Amlodipine and Hepatitis e - a phase IV clinical study of FDA data

Summary:

Hepatitis e is reported as a side effect among people who take Amlodipine (amlodipine besylate), especially for people who are male, 50-59 old, also take Methotrexate, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Hepatitis e when taking Amlodipine. It is created by eHealthMe based on reports of 346,875 people who have side effects when taking Amlodipine from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,830 Amlodipine users. Check the latest studies of Amlodipine.

What is Hepatitis e?

Hepatitis e is found to be associated with 117 drugs and 182 conditions by eHealthMe. Check the latest studies of Hepatitis e.

On Aug, 07, 2026

346,875 people reported to have side effects when taking Amlodipine.
Among them, 30 people (0.01%) have Hepatitis e.

Among these 30 people:

What is the gender of people who have Hepatitis e when taking Amlodipine? *

female: 26.67 %
male: 73.33 %

What is the age of people who have Hepatitis e when taking Amlodipine? *

What are other drugs people take besides Amlodipine? *

What are other side effects people have besides Hepatitis e? *

Hepatocellular Injury (liver injury): 5 people, 16.67%
Abdominal Pain Upper: 3 people, 10.00%
Oedema Mucosal (swelling of mucous membrane): 2 people, 6.67%
Gastric Mucosa Erythema (reddened mucosa of stomach): 2 people, 6.67%
Dyspnea (difficult or laboured breathing): 2 people, 6.67%
Gastritis Haemorrhagic (inflammation of stomach with bleeding): 2 people, 6.67%
Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 2 people, 6.67%
Diverticulum Intestinal Haemorrhagic (a pouch that is attached to the first part of the small intestine with bleeding): 2 people, 6.67%
Diaphragmatic Paralysis (acquired dysfunction of the phrenic nerve): 2 people, 6.67%
Constipation: 2 people, 6.67%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 16.67%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 10.00%
Type 2 Diabetes: 2 people, 6.67%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 6.67%
Interstitial Lung Disease: 2 people, 6.67%
Infection: 2 people, 6.67%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 6.67%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 6.67%
Hepatocellular Carcinoma (liver cancer): 1 person, 3.33%
Hepatic Steatosis (fatty liver disease): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Hepatitis e?

- Check whether Hepatitis e is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amlodipine:

Amlodipine (354,830 reports)

Hepatitis e treatments and more:

Hepatitis e (1,871 reports)

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis e:

Hepatitis e (117 drugs)

Browse all the conditions that are associated with Hepatitis e:

Hepatitis e (182 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.